Wei Sheng
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 5
- Oncology 16
- Chemokine receptors and signaling 4
- Co-authors
- Julie Y. DjeuKrithika N. KodumudiDanielle L. GilvaryEva SahakianKarrune WoanPearlie K. Epling‐BurnetteErika A. EksiogluXianghong Chen
- Journals
- Blood (6 papers)Frontiers in Cardiovascular Medicine (4 papers)Cancer Gene Therapy (2 papers)Poultry Science (1 paper)Cell Death Discovery (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wei Sheng
68 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 108
- Immunology 614
- Hematology 293
- Oncology 522
- Genetics 150
- Pharmacology 80
Countries citing papers authored by Wei Sheng
This map shows the geographic impact of Wei Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Sheng more than expected).
Fields of papers citing papers by Wei Sheng
This network shows the impact of papers produced by Wei Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Sheng. The network helps show where Wei Sheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 13 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 19 | |
| 8 | 2020 | 19 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 3 | |
| 11 | 2018 | 5 | |
| 12 | 2015 | 58 | |
| 13 | 2015 | 21 | |
| 14 | 2015 | 145 | |
| 15 | 2014 | 22 | |
| 16 | 2014 | 15 | |
| 17 | 2011 | 129 | |
| 18 | 2010 | 34 | |
| 19 | 2009 | 9 | |
| 20 | Immunoradiometric Assay for Serum Levels of Tumor Markers: CA72-4,CA19-9 and CEA in Gastric Cancer | 2000 | 1 |
About Wei Sheng
Wei Sheng is a scholar working on Hematology, Oncology, Genetics, Immunology and Pulmonary and Respiratory Medicine, having authored 72 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Immune cells in cancer (6 papers), Acute Myeloid Leukemia Research (5 papers), Aortic Disease and Treatment Approaches (5 papers), Aortic aneurysm repair treatments (4 papers), Chemokine receptors and signaling (4 papers), Cardiac Valve Diseases and Treatments (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Immunology (614 citations), Hematology (293 citations), Oncology (522 citations), Genetics (150 citations) and Pharmacology (80 citations). Wei Sheng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Julie Y. Djeu, Krithika N. Kodumudi, Danielle L. Gilvary, Eva Sahakian, Karrune Woan, Pearlie K. Epling‐Burnette, Erika A. Eksioglu, Xianghong Chen, Alan F. List and Junmin Zhou. Their work appears in journals such as Blood, Frontiers in Cardiovascular Medicine, Cancer Gene Therapy, Poultry Science and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.